GMOC — GMO ETF TRUST
As of Q2 2026, 3 SEC-registered investment managers reported holding GMOC (GMO ETF TRUST) in their latest 13F filings, with a combined reported value of $1.90M across 37.91K shares. That is +165.8% by share count (+23.65K shares) versus the previous quarter, while reported value moved +165.9%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 2 added to existing stakes. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Citadel Advisors history | Q2 2026 | 19.52K | $976.78K | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 10.89K | $544.99K | 0.00% | New |
| Goldman Sachs Group history | Q2 2026 | 7.50K | $375.34K | 0.00% | Add |
New Positions (Q2 2026)
- Morgan Stanley 10.89K sh · $544.99K
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 3 funds)
| Fund | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|
| Citadel Advisors | 11.26K | 9.66K | 19.52K |
| Morgan Stanley | — | — | 10.89K |
| Goldman Sachs Group | — | 4.60K | 7.50K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details